Form D · Pharmaceuticals
AtheroNova Inc.
Irvine, CA · CIK 0001377053
Offering snapshot reported Sep 16, 2014 · SEC filing
- Reported sold
- $500K Offering amount: $1M
- Investors reported
- 7 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 12, 2014 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 16, 2014 | Initial | $500,000 | No comparison | 7 | SEC filing |
| Mar 3, 2014 | Amendment | $1,906,500 | $1,556,500vs Jan 22, 2014 | 31 | SEC filing |
| Jan 22, 2014 | Initial | $350,000 | No comparison | 2 | SEC filing |
| Aug 21, 2013 | Initial | $270,000 | No comparison | 3 | SEC filing |
| Nov 1, 2012 | Initial | $2,925,000 | No comparison | 35 | SEC filing |
| Dec 20, 2011 | Amendment | $1,748,764 | $1,311,039vs May 12, 2011 | 47 | SEC filing |
| May 12, 2011 | Initial | $437,725 | No comparison | 7 | SEC filing |
| Jun 11, 2010 | Initial | $10,741,000 | No comparison | 21 | SEC filing |
Offering details
- Securities
- Debt, Option to acquire, Security to be acquired
- Exemptions
- 06c
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-224793
Source: Form D, filed Sep 16, 2014. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Chaim Davis | Director |
| Paul Di Perna | Director |
| Gary Freeman | Director |
| Thomas W Gardner | Director, Executive |
| Fred Knoll | Director |
| Alexander Polinksy | Director |
| Alexander Polinsky | Director |
| Boris Ratiner | Director |
| Mark Selawski | Executive |
| Johan M Spoor | Director |
| Filiberto Zadini | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
2301 Dupont Drive, Suite 525
Irvine, CA, 92612
Irvine, CA, 92612